找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Vascular Disruptive Agents for the Treatment of Cancer; Tim Meyer Book 2010 Springer Science+Business Media, LLC 2010 CT.angiogenesis.canc

[复制链接]
楼主: 代表
发表于 2025-3-26 23:38:41 | 显示全部楼层
发表于 2025-3-27 02:07:36 | 显示全部楼层
ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy
发表于 2025-3-27 06:12:06 | 显示全部楼层
Vascular Disruptive Agents in Combination with Radiotherapy
发表于 2025-3-27 12:21:12 | 显示全部楼层
Vascular Disruptive Agents for the Treatment of Cancer
发表于 2025-3-27 14:43:16 | 显示全部楼层
Vascular Disruptive Agents for the Treatment of Cancer978-1-4419-6609-4
发表于 2025-3-27 17:46:11 | 显示全部楼层
发表于 2025-3-28 00:52:53 | 显示全部楼层
发表于 2025-3-28 03:42:30 | 显示全部楼层
发表于 2025-3-28 08:27:02 | 显示全部楼层
Henry C. Mandeville,Peter J. Hoskinntibody molecules with significant affinity for that particular antigen. The former instructional theories of antibody formation clearly were rendered obsolete by this concept. Many scholars attribute the subsequent formal proof of clonal selection to Raff et al. (.).
发表于 2025-3-28 11:55:36 | 显示全部楼层
lities used to assess the efficacy of these agents are examiAngiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-7 13:29
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表